P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Summary

The primary purpose of the study is to investigate the effects of high-dose octreotide on flushing, diarrhea, and quality of life in patients whose disease-related symptoms are inadequately controlled by the maximum approved dose of octreotide LAR.

Timeline

Start

2013-12

Primary completion

2014-08

Completion

2014-10

Drugs

Indications